Argitalpenak (23) ANE MÍNGUEZ OLAONDO argitalpenak

2024

  1. Behavioral therapy in migraine: Expanding the therapeutic arsenal

    European Journal of Neurology

  2. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

  3. Nueva era terapéutica para el ataque de migraña con los recientemente aprobados anticuerpos monoclonales, ditanes y gepantes

    Revista de neurologia, Vol. 78, Núm. 2, pp. 47-57

  4. Visual snow syndrome in patients with migraine: widening the clinical spectrum of the syndrome with permanent and episodic manifestations

    Neurological Sciences, Vol. 45, Núm. 9, pp. 4437-4444

2023

  1. Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients

    Journal of Headache and Pain, Vol. 24, Núm. 1

  2. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  3. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, Núm. 9, pp. 635-646

2022

  1. Cutaneous Allodynia in Migraine: A Narrative Review

    Frontiers in Neurology, Vol. 12

  2. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  3. Headache: pregnancy and breastfeeding Recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 37, Núm. 1, pp. 1-12

  4. Nummular headache responsive to anti-calcitonin gene-related peptide monoclonal antibodies in a patient with migraine

    Headache, Vol. 62, Núm. 8, pp. 1063-1066

  5. Topiramate: neuropharmacology and clinical versatility

    Kranion, Vol. 17, pp. 20-25

2021

  1. Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients

    Expert Review of Neurotherapeutics, Vol. 21, Núm. 1, pp. 123-130

  2. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

    Journal of Headache and Pain, Vol. 22, Núm. 1

  3. Experiment in vivo: How COVID-19 Lifestyle Modifications Affect Migraine

    Frontiers in Neurology, Vol. 12

  4. Interictal amylin levels in chronic migraine patients: A case-control study

    Cephalalgia, Vol. 41, Núm. 5, pp. 604-612

  5. Neurological manifestations of endocrine disorders

    Endocrinology (Switzerland) (Springer Science and Business Media Deutschland GmbH), pp. 281-309

  6. Pituitary apoplexy causing thunderclap headache: Easy to miss

    Practical Neurology

  7. Tratamiento de las neuralgias

    Kranion, Vol. 16, pp. 27-32

2020

  1. Excess abdominal fat is associated with cutaneous allodynia in individuals with migraine: A prospective cohort study

    Journal of Headache and Pain, Vol. 21, Núm. 1